# Compass Therapeutics, Inc.: Form DEF 14A, filed Apr 28, 2022

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: DEF 14A
- Filed: 2022-04-28
- Accepted by EDGAR: Apr 28, 2022, 17:30 ET
- Period: 2022-05-24
- Accession: 0001140361-22-016447
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000114036122016447/edge20003463x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000114036122016447/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000114036122016447/edge20003463x1_def14a.htm

Filed Apr 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-016447. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.